Temporal trends of antithrombotic therapy for stroke prevention in Korean patients with non-valvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants: A nationwide population-based study

Atrial fibrillation risk in metabolically healthy obesity: A nationwide population-based study

(2017) HyunJung Lee et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Trends in the incidence and prevalence of atrial fibrillation and estimated thromboembolic risk using the CHA 2 DS 2 -VASc score in the entire Korean population

(2017) So-Ryoung Lee et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPEAN HEART JOURNAL

Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation

(2016) A John Camm et al.   HEART

Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry

(2016) Seil Oh et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Inadequate stroke prevention in Korean atrial fibrillation patients in the post-warfarin era

(2016) Eun Joo Choi et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Underweight is a risk factor for atrial fibrillation: A nationwide population-based study

(2016) Si-Hyuck Kang et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Evaluation of the association between diabetic retinopathy and the incidence of atrial fibrillation: A nationwide population-based study

(2016) So-Ryoung Lee et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Aspirin Instead of Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Risk for Stroke

(2016) Jonathan C. Hsu et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Stroke prevention in atrial fibrillation

(2016) Ben Freedman et al.   LANCET

Impact on Outcomes of Changing Treatment Guideline Recommendations for Stroke Prevention in Atrial Fibrillation: A Nationwide Cohort Study

(2016) Tze-Fan Chao et al.   MAYO CLINIC PROCEEDINGS

Should Atrial Fibrillation Patients With Only 1 Nongender-Related CHA2DS2-VASc Risk Factor Be Anticoagulated?

(2016) Laurent Fauchier et al.   STROKE

Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1

(2016) Raed A. Joundi et al.   STROKE

Rate-Control Treatment and Mortality in Atrial FibrillationCLINICAL PERSPECTIVE

(2015) Tze-Fan Chao et al.   CIRCULATION

Underutilization of warfarin for stroke prophylaxis in patients with atrial fibrillation or atrial flutter in Korea

(2015) Iyn-Hyang Lee et al.   Journal of Cardiology

Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA2DS2-VASc Score

(2015) Gregory Y.H. Lip et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation?

(2015) Tze-Fan Chao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score

(2015) Flemming Skjøth et al.   THROMBOSIS AND HAEMOSTASIS

The Korean Heart Rhythm Society's 2014 Statement on Antithrombotic Therapy for Patients with Nonvalvular Atrial Fibrillation: Korean Heart Rhythm Society

(2015) Byung Chun Jung et al.   Korean Circulation Journal

National Assessment of Warfarin Anticoagulation Therapy for Stroke Prevention in Atrial Fibrillation

(2014) Jeffrey S. Dlott et al.   CIRCULATION

Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naive atrial fibrillation patients: Danish nationwide descriptive data 2011-2013

(2014) J. B. Olesen et al.   EUROPACE

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

(2014) Craig T. January et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Real life anticoagulation treatment of patients with atrial fibrillation in Germany: extent and causes of anticoagulant under-use

(2014) Thomas Wilke et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Background and Data Configuration Process of a Nationwide Population-Based Study Using the Korean National Health Insurance System

(2014) Sun Ok Song et al.   Diabetes & Metabolism Journal

Warfarin use among older atrial fibrillation patients with non–ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy

(2013) Emil L. Fosbol et al.   AMERICAN HEART JOURNAL

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPEAN HEART JOURNAL

Underuse of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review

(2010) Isla M. Ogilvie et al.   AMERICAN JOURNAL OF MEDICINE

Moving the Tipping Point

(2010) Mark H. Eckman et al.  

Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach

(2009) Gregory Y.H. Lip et al.   CHEST

Sex Differences in Stroke Epidemiology

(2009) Peter Appelros et al.   STROKE